SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Zebec's integrated products - real time payroll apps, on-chain payments infrastructure and networked DePIN - serve companies of all sizes, merchants and individuals and help transcend the boundaries of traditional banking and diminish the role of financial intermediaries.

Zebec Network

ZBCNs sharp rally and apparent resistance breakout are driving attention, with traders anticipating further gains while others warn the move may fade. Some link the strength to Zebecs payroll and card expansion or speculate about Robinhood and BlackRock involvement, but those rumored connections are unconfirmed.

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

New 24-month HOPE-3 extension data presented at the World Muscle Society, suggesting slower upper-limb decline after patients switched to deramiocel, drove attention to CAPR. Traders largely welcomed the results as support for the drug ahead of FDA review, while others cautioned that the data may not resolve the agencys earlier statistical and efficacy concerns.

AbCellera Biologics, Inc. engages in the development of therapeutic antibodies. It offers antibody discovery platform that searches, decodes and analyzes natural immune systems to find antibodies that can be developed to prevent and treat disease. The company was founded by Carl Lars G. Hensen, Kathleen Lisaingo, Kevin Heyries, Véronique Lecault and Daniel Da Costa on November 8, 2012 and is headquartered in Vancouver, Canada.

AbCellera Biologics Inc

Positive Phase 2 results for AbCelleras ABCL635 menopause treatment and an upcoming presentation of additional trial data are driving discussion, with JPMorgans Overweight initiation adding support. Traders are broadly bullish on the clinical potential, while some caution that durability and success in larger trials remain unproven.

SoFi Technologies, Inc. is a financial service platform, which engages in the provision of student loan refinancing options to the private student loan market. It operates through the following segments: Lending, Technology Platform, and Financial Services. The Lending segment offers personal loans, student loans, home loan products, and related servicing activities. The Technology Platform segment focuses on technology products and solutions revenue. The Financial Services segment includes the SoFi Money product, SoFi Invest product, SoFi Credit Card product, SoFi Relay personal finance management product, and other financial services. The company was founded in April 2011 and is headquartered in San Francisco, CA.

SoFi Technologies Inc

SOFI is drawing attention amid a prolonged share-price decline, with traders blaming prior dilutive offerings, insider selling, higher-rate concerns and heavy short interest. Frustrated bears see continued downside and fault management, while bulls argue the companys growth and progress are not reflected in the stock.

Lockheed Martin Corp. is a global security and aerospace company, which engages in the research, design, development, manufacture, integration, and sustainment of technology systems, products, and services. It operates through the following business segments: Aeronautics, Missiles and Fire Control (MFC), Rotary and Mission Systems (RMS), and Space. The Aeronautics segment researches, designs, develops, manufactures, integrates, sustains, supports, and upgrades advanced military aircraft, including combat and air mobility aircraft, unmanned air vehicles, and related technologies. The MFC segment is involved in air and missile defense systems, tactical missiles and air-to-ground precision strike weapon systems, logistics, fire control systems, mission operations support, readiness, engineering support and integration services, manned and unmanned ground vehicles, and energy management solutions. The RMS segment designs, manufactures, services, and supports various military and commercial helicopters, surface ships, sea and land-based missile defense systems, radar systems, sea and air-based mission and combat systems, command and control mission solutions, cyber solutions, and simulation and training solutions. The Space segment includes the production of satellites, space transportation systems, and strategic, advanced strike, and defensive systems. The company was founded in 1995 and is headquartered in Bethesda, MD.

Lockheed Martin Corp.

Lockheed Martin is drawing attention amid a broader defense-sector selloff, with traders questioning why shares are falling despite strong missile demand, large backlogs and new contract activity. Some see the pullback as a buying opportunity, while others cite budget and election uncertainty, sector rotation and continued downside risk.

Goodyear Tire & Rubber Co. engages in the development, manufacture, distribution, and sale of tires. It operates through the following geographical segments: Americas, Europe, Middle East, and Africa, and Asia Pacific. The Americas segment is involved in the development, manufacture, distribution, and sale of tires and related products and services in North, Central, and South America. The Europe, Middle East, and Africa segment focuses on the development, manufacture, distribution, and sale of tires for automobiles, trucks, buses, aircraft, motorcycles, earthmoving, mining, and industrial equipment throughout Europe, the Middle East, and Africa. The Asia Pacific segment refers to the development, manufacture, distribution, and sales of tires for automobiles, trucks, buses, aircraft, farm, earthmoving, mining, and industrial equipment throughout the Asia Pacific region. The company was founded by Frank A. Seiberling on August 29, 1898 and is headquartered in Akron, OH.

Goodyear Tire & Rubber Co.

Traders are speculating about a possible buyout or take-private deal and a short squeeze, fueled by Goodyears depressed share price and sharp moves; no deal is confirmed. Others point to the companys debt, weak performance and exposure to oil costs as reasons for caution.

Robinhood GLD is a tokenized representation of SPDR Gold Shares (GLD) common stock, issued on Robinhood Chain, Robinhood's own blockchain built to bring tokenized real-world assets on-chain. Each token is designed to track the price of the underlying GLD share, giving holders on-chain price exposure to SPDR Gold Shares's stock. The token is freely transferable and composable across the Robinhood Chain ecosystem. It's part of Robinhood's broader initiative to expand access to tokenized U.S. equities via blockchain technology, alongside a wider lineup of tokenized stock tokens launching on the same network.

GoldCoin

Golds recent weakness is the dominant topic, with traders linking pressure on the metal to rising Treasury yields, a stronger dollar, and expectations of tighter Fed policy. The community is divided between buyers watching for a base or rebound and bearish traders expecting further downside; some posts also appear to confuse the ticker with tokenized gold or other crypto.

Iovance Biotherapeutics, Inc. engages in the development and commercialization of cell therapies using autologous tumor-infiltrating lymphocytes (TIL) for the treatment of cancer. Its products include Amtagvi (lifileucel), and Proleukin (aldesleukin). The firm also develops investigational TIL therapies for other solid tumor cancers. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA.

Iovance Biotherapeutics Inc

Iovances raised 2026 revenue outlook, reflecting stronger demand for Amtagvi and Proleukin, is driving the sharp rally and renewed analyst optimism. Traders are debating whether heavy short covering is amplifying the move, while also watching for a pullback and upcoming lung-cancer data.

Invesco QQQ Trust Series 1 - Invesco QQQ Trust Series 1

QQQ discussion centers on choppy trading amid elevated Treasury yields and uncertainty over further Fed rate hikes, with traders focused on PCE inflation data and Micron earnings for direction. Some see resilient dip-buying and AI-led momentum, while others warn that high rates and AI-capex concerns could leave the market vulnerable to a pullback.

Micron Technology, Inc. engages in the provision of innovative memory and storage solutions. It operates through the following segments: Cloud Memory Business Unit (CMBU), Core Data Center Business Unit (CDBU), Mobile and Client Business Unit (MCBU), and Automotive and Embedded Business Unit (AEBU). The CMBU segment focuses on memory solutions for large hyperscale cloud customers and High-Bandwidth Memory for all data center customers. The CDBU segment is involved in memory solutions for mid-tier cloud, enterprise, and OEM data center customers and storage solutions for all data center customers. The MCBU segment focuses on memory and storage solutions for the mobile and client segments. The AEBU segment is involved in memory and storage solutions for the automotive, industrial, and consumer segments. The company was founded by Ward D. Parkinson, Joseph Leon Parkinson, Dennis Wilson, and Doug Pitman on October 5, 1978 and is headquartered in Boise, ID.

Micron Technology Inc.

Micron Technology Inc

Microns fiscal Q4 earnings and forward guidance are the dominant focus, with traders watching whether AI-driven memory demand, tight DRAM and NAND supply, and pricing strength can support continued growth. Many expect strong results, while others warn that high expectations may already be priced in and debate whether the memory cycle can last, raising the risk of a sell-the-news reaction.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Enzolytics, Inc. is a biotechnology company, which engages in the development and commercialization of drugs for infectious disease treatments. The company’s all-human monoclonal antibodies target and neutralize human immunodeficiency virus and are being employed to produce anti-SARS-CoV-2 monoclonal antibodies for treating COVID-19. Its proprietary therapeutic is also being tested against Hepatitis A, B and C, Rheumatoid Arthritis, certain forms of cancer, rabies, influenza A and B, tetanus, and diphtheria. The company was founded on July 28, 2004 and is headquartered in Allen, TX.

Enzolytics Inc

Bullish Sentiment

Adding risk (buying more)

Trimming/taking profits

Rotating into safer assets

Staying the course, no changes

We&#39;re about to enter Q4 - how are you positioning your portfolio for the rest of the year?

Stocktwits

We're about to enter Q4 - how are you positioning your portfolio for the rest of the year?

Microsoft Corp

Meta Platforms Inc

SELLAS Life Sciences Group Inc

Alphabet Inc Class A

CoreWeave Inc

SpaceX

Stocktwits Polls

$ENZC Whenever a nobody company claims to have secret science that can only be understood by retail investors, you know it's a scam.  This company scammed people by having useful idiots like @GawdyPanther and Mark FTW, who were complete morons, convince people that understanding the "science" made them part of a special group.  The reality was, the science of conserved sites was prevalent, but legitimate companies knew they couldn't patent a site on a virus.  ENZC was the only company promoting that myth, and that made them seem special.  Instead, they were pursuing patents that Charles had to know would not be approved.  And all the while, they were getting paid, and hoped to continue their payments through the SAGA sham.  Hell, even the wives were going to be put on the payroll.  It's all so obvious now, isn't it?

$ENZC The loudmouths have all taken cover or deleted their accounts.  Remember that tough guy Everson?  It's like he never existed.  That's what these scams rely on.  People who invest their hard-earned money and never say a bad word about the company because it hurts their investment, in their mind.  The scammed get angry and attack skeptics who show how the company is misleading shareholders and might be a scam.  Then once it's over, the scammed take their losses and quietly move on.  That's who the scammers target.  That's why the scammer wants to silence the skeptics with loudmouths like Everson and enforcers like @GawdyPanther and @GodfatherCap .  To keep the boards clean so people like Everson  keep buying and hold to zero.

$ENZC remember when the idiots in the discord told everyone to not use stop losses because the imaginary "shorts" can see them. Meanwhile their hero company leaders were the ones dumping all over them. Company leaders were probably in the discord manipulating the shit out of the situations. Putting out a PR, pump, pump, pump, sell, sell, sell.

Arnold

$ENZC I guess nobody buying these a$$holes bullshit anymore and rightfully so. To all those that were pumping this shit from Dr. Chandra to the paid pumpers....a very big fu©k you!!!

Ahmar rashid

$ENZC I'm hoping some of the people pushing this trash start giving courtesy licks. It would make getting railed so hard much better

ENZC Enzolytics Inc